Sign in

CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Aura Biosciences, Inc.

Sign in to watch
Ticker
AURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320271970
Phone
(617)500-8864
Business address
80 GUEST STREET, BOSTON, MA, 02135
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Other events
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. 4 Grant or award Chief People Officer acquired 107,611 shares (grant or award)
  6. 4 Grant or award Chief Reg. & Quality Officer acquired 100,885 shares (grant or award)
  7. 4 Grant or award Chief Medical Officer acquired 58,850 shares (grant or award)
  8. 4 Grant or award SVP, Finance & PAO acquired 23,540 shares (grant or award)
  9. 4 Grant or award Chief Operating Officer acquired 134,513 shares (grant or award)
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. EFFECT Other Notice of Effectiveness
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. UPLOAD Other SEC-generated Letter
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. S-3 Offering Registration Statement

Page 1 of 20 · 383 filings